About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

Menopause, Cholesterol and Cardiovascular Disease

Citation:

US Cardiology 2008;5(1):12–4

Homocysteine and Heart Disease

Citation:

US Cardiology 2004;1(1):1-4

Management of Cholesterol in Diabetes - A Review

Citation:

US Cardiology 2010;7(2):20–4

Treatment Strategies for Patients with Acute Carotid Syndromes

Citation:

US Cardiology 2009;6(2):84–6